The modulatory role of GABA in the triple network and its impact on anhedonia and cognitive function in depression
Yiwen Wang1, Mengzhi Zhang1, Azi Shen1
1Nanjing Brain Hospital, Clinical Teaching Hospital of Medical School, Nanjing University, Nanjing, China.
Background:
GABAergic dysfunction contributes to Major Depressive Disorder (MDD). This study examines excitatory/inhibitory (E/I) imbalance, specifically GABA deficits in the left dorsolateral prefrontal cortex (DLPFC), and their link to anhedonia and cognitive impairment in MDD. It also investigates alterations in the coupling between local E/I activity and functional connectivity (FC) within the triple network.
Methods:
We included 41 medication-naïve MDD patients and 33 healthy controls (HCs). Participants underwent Snaith-Hamilton Pleasure Scale (SHAPS) and cognitive assessments. GABA+/Cr, Glx, and GABA+/Glx ratios were measured in the left DLPFC using proton magnetic resonance spectroscopy (¹H-MRS). Resting-state functional magnetic resonance imaging (fMRI) data were analyzed via independent component analysis (ICA), identifying five major brain networks.
Results:
Female MDD patients exhibited reduced GABA+/Cr in the left DLPFC (p = 0.021). GABA+/Cr negatively correlated with SHAPS scores (r = -0.33, p = 0.04) and Trail Making Test Part B (TMT-B) completion times (r = -0.36, p = 0.03) in MDD patients. HCs showed positive correlations between GABA+/Cr and FC within the LECN (r = 0.41, p = 0.02) and between the LECN-dDMN (r = 0.39, p = 0.03) and LECN-pSN (r = 0.46, p = 0.01); these correlations were absent in the MDD group.
Conclusions:
Female patients with MDD exhibit a specific reduction in GABA levels in the left DLPFC. Furthermore, these lower GABA levels are associated with increased anhedonia and poorer executive function. Critically, the neurochemical coupling between GABA and large-scale brain networks is also disrupted in MDD.
More Related Videos
05:17BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain
Published on: May 26, 2023
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
Neurotransmitters
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
G-protein Coupled Receptors
CNS Depressants: Alcohol and Nicotine
